Related Experiment Video
Updated: Mar 31, 2026

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells
Published on: June 3, 2012
Battle between influenza A virus and a newly identified antiviral activity of the PARP-containing ZAPL protein
Chien-Hung Liu1, Ligang Zhou1, Guifang Chen1
1Department of Molecular Biosciences, Center for Infectious Disease, Institute for Cellular and Molecular Biology, University of Texas, Austin, TX 78712.
Abstract:
Previous studies showed that ZAPL (PARP-13.1) exerts its antiviral activity via its N-terminal zinc fingers that bind the mRNAs of some viruses, leading to mRNA degradation. Here we identify a different antiviral activity of ZAPL that is directed against influenza A virus. This ZAPL antiviral activity involves its C-terminal PARP domain, which binds the viral PB2 and PA polymerase proteins, leading to their proteasomal degradation. After the PB2 and PA proteins are poly(ADP-ribosylated), they are associated with the region of ZAPL that includes both the PARP domain and the adjacent WWE domain that is known to bind poly(ADP-ribose) chains. These ZAPL-associated PB2 and PA proteins are then ubiquitinated, followed by proteasomal degradation. This antiviral activity is counteracted by the viral PB1 polymerase protein, which binds close to the PARP domain and causes PB2 and PA to dissociate from ZAPL and escape degradation, explaining why ZAPL only moderately inhibits influenza A virus replication. Hence influenza A virus has partially won the battle against this newly identified ZAPL antiviral activity. Eliminating PB1 binding to ZAPL would be expected to substantially increase the inhibition of influenza A virus replication, so that the PB1 interface with ZAPL is a potential target for antiviral development.
Insights
Zinc finger antiviral protein (ZAPL) targets influenza A virus polymerase proteins PB2 and PA for degradation. Viral protein PB1 interferes, reducing ZAPL
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Zinc finger antiviral protein (ZAPL), also known as PARP-13.1, previously demonstrated antiviral functions through mRNA binding.
- Influenza A virus (IAV) poses a significant global health threat, necessitating novel antiviral strategies.
Purpose of the Study:
- To elucidate the mechanism of ZAPL's antiviral activity against influenza A virus.
- To identify host-pathogen interactions that regulate ZAPL-mediated inhibition of IAV replication.
Main Methods:
- Co-immunoprecipitation assays to detect protein-protein interactions.
- Western blotting to assess protein levels and ubiquitination.
- Proteasomal degradation assays.
- Analysis of ZAPL's interaction with viral polymerase subunits (PB1, PB2, PA).
Main Results:
- ZAPL inhibits influenza A virus replication through its C-terminal PARP domain, distinct from its previously known N-terminal antiviral mechanism.
- ZAPL's PARP domain binds viral PB2 and PA proteins, leading to their poly(ADP-ribosylation), ubiquitination, and subsequent proteasomal degradation.
- The viral PB1 polymerase protein counteracts ZAPL activity by binding near the PARP domain, preventing PB2 and PA dissociation and degradation.
- IAV replication is only moderately inhibited by ZAPL due to this counteraction by PB1.
Conclusions:
- A novel ZAPL-mediated antiviral pathway targeting IAV polymerase proteins PB2 and PA has been identified.
- Influenza A virus has evolved a mechanism involving PB1 to evade ZAPL-mediated degradation.
- The PB1-ZAPL interface represents a potential therapeutic target for developing new antiviral drugs against influenza A virus.
More Related Videos
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
22:10Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
Related Concept Videos
Leaky Scanning
Influenza
Viral Recombination
Restarting Stalled Replication Forks
The Antiviral System of Bacteria and Archaea: CRISPR
Inhibitors of Viral Protein Synthesis